Richard Kimball

 

Richard Kimball - Professional Summary:  

 

A financial services and investment banking executive with more than 20 years of experience in his field, Richard Kimball, Jr. currently serves as a Managing Director at Goldman Sachs in New York. Commanding a strong academic and professional background, Richard Kimball, Jr. laid the foundations for his career as an undergraduate at Yale University, where he pursued studies in a broad range of subjects. An Economics major, Richard Kimball, Jr. focused his energy on topics of international finance, computer science, and mechanical engineering, with particular emphasis on the Japanese bond futures market. Upon receipt of his Bachelor’s degree in 1986, Richard Kimball, Jr. secured an entry-level role at Morgan Stanley as an Analyst in Equity Capital Markets. From the beginning, Richard Kimball, Jr. demonstrated his potential with Morgan Stanley, proving instrumental in the acquisition of a $400 million CBS convertible, noted by the International Financing Review as the “Deal of the Year.” After stints as an Analyst and Associate in Corporate Finance, Richard Kimball, Jr. moved into the Equity Capital Markets division, where he rose from Associate to Managing Director over a seven-year period. Leaving the company to found Millennium Technology Ventures in 2000, Richard Kimball, Jr. returned two years later and assumed responsibilities as Managing Director of Healthcare Services Investment Banking, followed by a term as Managing Director of Healthcare Equity Capital Markets. In 2005, Richard Kimball, Jr. accepted an offer to become a Managing Director in Equity Capital Markets at Goldman Sachs, in which he executes various types of financing for companies in the healthcare, retail, and consumer products industries. Today, Richard Kimball, Jr. is Co-Head of Global Healthcare Investment Banking and Co-head of the Healthcare, Consumer and Retail Financing Group at Goldman Sachs.

 

Richard Kimball - Professional Experience:    

 

Goldman Sachs 2005-Present

Managing Director, Equity Capital Markets

Lead the Firm’s Healthcare, Consumer and Retail Capital Markets business. Recently executed financings for Healthspring, Wellcare Health Plans, Amylin, Web MD Health, Myogen. Maintain active dialogue with major healthcare companies in all subsectors including large cap pharma, specialty pharma, biotech, medtech and healthcare services.

 

Morgan Stanley 2002-2005

Managing Director, Equity Capital Markets 2004-2005

Led the Firm’s Healthcare Equity Capital Markets business. Executed $3.1bn of healthcare equity new issues in 2004 including major convertible new issues for Imclone, Sepracor, Chiron, American Medical Optics, highly successful IPO and secondary for Wellcare Health Plans and follow-on offerings for Eyetech, Pharmion, Incyte, Amylin among others. Advised Renal Care Group in its $4bn sale to Fresenius.

Managing Director, Healthcare Services Investment Banking 2002-2004

Managed the Firm’s investment banking relationships in the managed care, hospital, distribution, pharmacy benefit management and healthcare IT sectors. Advised UnitedHealth Group on acquisition of Oxford Health Plans; sold Definity Health to UnitedHealth Group. Developed the Firm’s strategy to re-build the healthcare services group.

 

Richard Kimball - Education:   

 

Yale University, BA Economics, 1986. Concentrations in international finance, mechanical engineering and computer science. Senior essay on the Japanese bond futures market.

 

Richard Kimball - LookupPage

Richard Kimball - Xing

Richard Kimball - Multiply